RT @Heart_BMJ: Efficacy and safety of colchicine for the treatment of myopericarditis

RT @Heart_BMJ: The final stop for @kazemr was Shanghai. There he visited Shanghai Chest Hospital, Zhongshan Hospital at Fudan University an…

RT @Heart_BMJ: Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes =

RT @nathalie_conrad: Today @bmj_latest published our analysis of long-term trends in cardiovascular disease (CVD) burden We wanted to know…

RT @Heart_BMJ: Management of arrythmias during pregnancy

An aspirin in your pocket and self-administered after onset of severe chest pain could save your life. Simple, accessible, affordable...

RT @Heart_BMJ: Regional variations in heart failure: a global perspective � 🗺️

Patients prescribed a loop diuretic without a recorded diagnosis of heart failure (HF) experience HF events at a rate comparable with that of patients with a recorded diagnosis of HF; many of these patients may have undiagnosed HF. @JJCuthbert

Is your heart rate too high or too low? A new study in Heart shows that the ambulatory heart rate varies substantially among healthy middle-aged individuals, and it does not correlate well with clinical factors.

The European Sciecity of Cardiology's algorithm based on 0/1-hour high-sensivitity cardiac troponin T levels does not safely rule out cardiac death or myocardial infraction at 30 days in older and middle-aged adults. @Nick_Ashburn1 @Heart_BMJ

RT @Jonathan_K_Cook: One doesn't need to be a fortune-teller to understand that the Israel-US game plan for Gaza runs something like this:…

RT @Heart_BMJ: Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer htt…

RT @Heart_BMJ: Associations between air pollution and the risk of first admission and multiple readmissions for cardiovascular diseases htt…

Risk factor control in #diabetes can help prevent arrhythmias: "Although microvascular disease, a non-traditional risk factor, was associated with incident arrhythmias in individuals with T2D, having optimal levels of risk factors may mitigate this risk."

Impressive findings from the PolyPars trial just published in @Heart_BMJ : "The fixed-dose combination therapy using polypill can safely halve the risk of major cardiovascular diseases at the population level."

RT @LancetLongevity: Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (…

It is not just the first admission that is affected.

RT @Heart_BMJ: Role of coronary computed tomography angiography to optimise percutaneous coronary intervention outcomes

RT @raodyrao: Deep Medicine is hiring! Join us and be part of high-impact multidisciplinary research on AI for EHR/multimodal data. Link 👇…

RT @DrAiLynTan: Patients with #gout has excess risk of #cardiovascular diseases Need to ✅Reduce cardiovascular risk in people with gout ✅I…